Global Narcolepsy Drugs Market Report 2024-2032: Therapeutic Types, Disease Types, End Users, Countries, and Company Analysis Featuring Jazz Pharmaceuticals, Ligand Pharmaceuticals, Novartis, and More
July 30, 2024 08:01 ET
|
Research and Markets
Dublin, July 30, 2024 (GLOBE NEWSWIRE) -- The "Global Narcolepsy Drugs Market Report by Therapeutic Type Disease Type End Users Countries and Company Analysis, 2024-2032" report has been added to ...
Narcolepsy Drugs Industry Outlook to 2030: Emphasizing Growth in the Sodium Oxybate and Central Nervous System Stimulants Segments
January 24, 2024 14:35 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Narcolepsy Drugs Market (By Therapeutic Type, Disease Type, End User, Regional Analysis), Pipeline Analysis, Key Company Profiles and Recent...
Sodium Oxybate Takes Center Stage in Narcolepsy Treatment: Key Player in $5.95 Billion Narcolepsy Drugs Industry by 2030
November 07, 2023 06:48 ET
|
Research and Markets
Dublin, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The "Narcolepsy Drugs Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has...
The Worldwide Narcolepsy Therapeutics Industry is Projected to Reach $3.6 Billion by 2030 at a CAGR of 7.3%
February 16, 2023 11:33 ET
|
Research and Markets
Dublin, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The "Narcolepsy Therapeutics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Narcolepsy...
Global Narcolepsy Therapeutics Market Report to 2028: Growing Healthcare Expenditures and Increasing Prevalence of Neurological Conditions are Driving Factors
November 10, 2022 07:08 ET
|
Research and Markets
Dublin, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The "Global Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin...
$4.5 Billion Worldwide Narcolepsy Drugs Industry to 2027 - Featuring Avadel Pharmaceuticals, Axsome Therapeutics, Bioprojet Pharma and Graymark Healthcare Among Others
October 10, 2022 05:23 ET
|
Research and Markets
Dublin, Oct. 10, 2022 (GLOBE NEWSWIRE) -- The "Narcolepsy Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Global Narcolepsy Therapeutics Market Analysis and Forecasts, 2021-2022 & 2032: Available Therapies, Robust Pipeline Products, Rising Uptake of Narcolepsy Awareness Programs, and Improving Diagnosis
August 19, 2022 07:53 ET
|
Research and Markets
Dublin, Aug. 19, 2022 (GLOBE NEWSWIRE) -- The "Narcolepsy Therapeutics Market - A Global and Country Level Analysis: Focus on Therapeutics, Indication, Product, and Country - Analysis and Forecast,...
Global Narcolepsy Drugs Market Report 2022 - Sodium Oxybate Dominates, Owing to Its Dual-Pronged Approach in Treating Daytime Extreme Sleepless and Cataplexy
February 28, 2022 05:28 ET
|
Research and Markets
Dublin, Feb. 28, 2022 (GLOBE NEWSWIRE) -- The "Global Narcolepsy Drugs Market, Size, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis" report has been...
Global Narcolepsy Drugs Market (2021 to 2026) - Growth Trends and Forecasts
January 19, 2022 05:13 ET
|
Research and Markets
Dublin, Jan. 19, 2022 (GLOBE NEWSWIRE) -- The "Narcolepsy Drugs Market - Global Industry Analysis (2018 - 2020) - Growth Trends and Market Forecast (2021 - 2026)" report has been added to...
Insights on the Narcolepsy Drugs Global Market to 2030 - Narcolepsy Awareness Programs and Services Are Driving Growth
January 05, 2022 05:43 ET
|
Research and Markets
Dublin, Jan. 05, 2022 (GLOBE NEWSWIRE) -- The "Narcolepsy Drugs Market by Disease and Therapeutic Type: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to...